RCP Diagnostics Licenses Technology
Phoenix, Arizona-based RCP Diagnostics announced this morning that it has licensed its protein marker, for use in a blood diagnostic test for breast cancer. RCP said that it has licensed its protein marker to fellow Arizona firm Biomarker Technologies, which is developing a blood test for identifying cancer based on biomarkers. Financial terms were not disclosed. The licensing covers Biomarker's use of RCP's marker only for the diagnosis of breast cancer.
posted on Thursday, May 11, 2006
Related companies:
RCP Compass Datacenters SPV LP
Related stories:
> Co-Diagnostics Snags Patent
> BioFire Diagnostics Lands $25M For Molecular Diagnostics Tools
> MBio Diagnostics Gets $6M
> Exagen Diagnostics Names COO
> Startup Licenses Technology Developed At BYU
Techrockies.com Home